NEW YORK (GenomeWeb) – Illumina reported after the close of the market Monday that its third quarter revenues climbed 35 percent year over year, as the firm easily beat Wall Street estimates on the top and bottom lines.

The San Diego-based genetic analysis products firm brought in total revenues of $480.6 million for the three months ended Sept. 28, compared to $356.8 million for the third quarter of 2013. Analysts, on average, had expected total revenues of $451.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.